No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪11.76 B‬AUD
‪60.65 M‬AUD
‪124.90 M‬AUD
‪50.25 M‬
Beta (1Y)


Sam Aaron Hupert
Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. It provides services in the form of installation and support. The firm offers a range of products including radiology information systems, picture archiving and communication systems. It also offers workflow mapping and optimization, network design and implementation, hardware sourcing, and configuration as well as staff and management training. The company was founded by Sam Aaron Hupert and Anthony Barry Hall in 1983 and is headquartered in Richmond, Australia.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PME is 114.82 AUD — it has increased by 1.92% in the past 24 hours. Watch PRO MEDICUS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PRO MEDICUS LIMITED stocks are traded under the ticker PME.
PME stock has fallen by 2.90% compared to the previous week, the month change is a 10.96% rise, over the last year PRO MEDICUS LIMITED has showed a 89.25% increase.
We've gathered analysts' opinions on PRO MEDICUS LIMITED future price: according to them, PME price has a max estimate of 152.68 AUD and a min estimate of 57.86 AUD. Watch PME chart and read a more detailed PRO MEDICUS LIMITED stock forecast: see what analysts think of PRO MEDICUS LIMITED and suggest that you do with its stocks.
PME reached its all-time high on May 16, 2024 with the price of 121.77 AUD, and its all-time low was 0.16 AUD and was reached on Jun 27, 2011. View more price dynamics on PME chart.
See other stocks reaching their highest and lowest prices.
PME stock is 2.03% volatile and has beta coefficient of 1.19. Track PRO MEDICUS LIMITED stock price on the chart and check out the list of the most volatile stocks — is PRO MEDICUS LIMITED there?
Today PRO MEDICUS LIMITED has the market capitalization of ‪11.76 B‬, it has increased by 0.41% over the last week.
Yes, you can track PRO MEDICUS LIMITED financials in yearly and quarterly reports right on TradingView.
PRO MEDICUS LIMITED is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
PME earnings for the last quarter are −0.35 AUD per share, whereas the estimation was 0.36 AUD resulting in a −195.34% surprise. The estimated earnings for the next quarter are 0.42 AUD per share. See more details about PRO MEDICUS LIMITED earnings.
PRO MEDICUS LIMITED revenue for the last quarter amounts to ‪74.11 M‬ AUD despite the estimated figure of ‪76.97 M‬ AUD. In the next quarter revenue is expected to reach ‪85.59 M‬ AUD.
PME net income for the last quarter is ‪36.25 M‬ AUD, while the quarter before that showed ‪33.46 M‬ AUD of net income which accounts for 8.34% change. Track more PRO MEDICUS LIMITED financial stats to get the full picture.
PRO MEDICUS LIMITED dividend yield was 0.46% in 2023, and payout ratio reached 51.64%. The year before the numbers were 0.52% and 51.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PRO MEDICUS LIMITED EBITDA is ‪104.03 M‬ AUD, and current EBITDA margin is 73.50%. See more stats in PRO MEDICUS LIMITED financial statements.
Like other stocks, PME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PRO MEDICUS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PRO MEDICUS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PRO MEDICUS LIMITED stock shows the buy signal. See more of PRO MEDICUS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.